• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆抗体的理化稳定性:综述。

Physicochemical Stability of Monoclonal Antibodies: A Review.

机构信息

Université Clermont Auvergne, CHU Clermont Ferrand, CNRS, Sigma Clermont, ICCF, F-63000 Clermont-Ferrand, France.

Université Clermont Auvergne, CHU Clermont Ferrand, CNRS, Sigma Clermont, ICCF, F-63000 Clermont-Ferrand, France.

出版信息

J Pharm Sci. 2020 Jan;109(1):169-190. doi: 10.1016/j.xphs.2019.08.009. Epub 2019 Aug 26.

DOI:10.1016/j.xphs.2019.08.009
PMID:31465737
Abstract

Monoclonal antibodies (mAbs) are subject to instability issues linked to their protein nature. In this work, we review the different mechanisms that can be linked to monoclonal antibodies instability, the parameters, and conditions affecting their stability (protein structure and concentration, temperature, interfaces, light exposure, excipients and contaminants, and agitation) and the different analytical methods used for appropriate physicochemical stability studies: physical stability assays (aggregation, fragmentation, and primary, secondary, and tertiary structure analysis), chemical stability assays and quantitative assays. Finally, data from different published stability studies of mAbs formulations, either in their reconstituted form, or in diluted ready to administer solutions, was compiled. Overall, the physicochemical stability of mAbs is linked to numerous factors such as formulation, environment, and manipulations, and must be thoroughly investigated using several complementary analytical techniques, each of which allowing specific characterization information to be harvested. Several stability studies have been published, some of them showing possibilities of extended stability. However, those data should be questioned due to potential lacks in study methodology.

摘要

单克隆抗体(mAbs)存在与其蛋白质性质相关的不稳定性问题。在这项工作中,我们综述了可能与单克隆抗体不稳定性相关的不同机制、影响其稳定性的参数和条件(蛋白质结构和浓度、温度、界面、光照、赋形剂和污染物以及搅拌),以及用于适当物理化学稳定性研究的不同分析方法:物理稳定性测定(聚集、碎片化以及一级、二级和三级结构分析)、化学稳定性测定和定量测定。最后,编译了不同已发表的 mAbs 制剂稳定性研究的数据,无论是在其重构形式还是在稀释的即用型溶液中。总体而言,mAbs 的物理化学稳定性与制剂、环境和操作等诸多因素有关,必须使用几种互补的分析技术进行彻底研究,每种技术都可以获取特定的特征信息。已经发表了一些稳定性研究,其中一些显示了延长稳定性的可能性。然而,由于研究方法可能存在缺陷,这些数据应受到质疑。

相似文献

1
Physicochemical Stability of Monoclonal Antibodies: A Review.单克隆抗体的理化稳定性:综述。
J Pharm Sci. 2020 Jan;109(1):169-190. doi: 10.1016/j.xphs.2019.08.009. Epub 2019 Aug 26.
2
Hydrogen-deuterium exchange mass spectrometry as an emerging analytical tool for stabilization and formulation development of therapeutic monoclonal antibodies.氢-氘交换质谱法作为一种新兴的分析工具,用于治疗性单克隆抗体的稳定性研究和制剂开发。
J Pharm Sci. 2015 Feb;104(2):327-45. doi: 10.1002/jps.24224. Epub 2014 Oct 29.
3
Physical Stability Studies of Antibody-Drug Conjugates (ADCs) Under Stressed Conditions.抗体药物偶联物(ADC)在应激条件下的物理稳定性研究。
Methods Mol Biol. 2020;2078:301-311. doi: 10.1007/978-1-4939-9929-3_21.
4
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
5
Managing antibody stability: Effects of stressors on Ipilimumab from the commercial formulation to diluted solutions.管理抗体稳定性:从商业制剂到稀释溶液的伊匹单抗的应激原的影响。
Eur J Pharm Biopharm. 2022 Jul;176:54-74. doi: 10.1016/j.ejpb.2022.05.005. Epub 2022 May 17.
6
Assessing Physicochemical Stability of Monoclonal Antibodies in a Simulated Subcutaneous Environment.评估单克隆抗体在模拟皮下环境中的理化稳定性。
J Pharm Sci. 2024 Jul;113(7):1854-1864. doi: 10.1016/j.xphs.2024.02.004. Epub 2024 Feb 9.
7
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability.生物制药制剂中的替代缓冲液系统及其对蛋白质稳定性的影响。
Acta Pharm. 2024 Sep 14;74(3):479-493. doi: 10.2478/acph-2024-0022. Print 2024 Sep 1.
8
Use of Peptide Microarrays for Fast and Informative Profiling of Therapeutic Antibody Formulation Conditions.使用肽微阵列对治疗性抗体配方条件进行快速且信息丰富的分析。
Mol Pharm. 2021 Nov 1;18(11):4131-4139. doi: 10.1021/acs.molpharmaceut.1c00543. Epub 2021 Oct 18.
9
Shipping-Induced Aggregation in Therapeutic Antibodies: Utilization of a Scale-Down Model to Assess Degradation in Monoclonal Antibodies.治疗性抗体中运输诱导的聚集:利用缩小模型评估单克隆抗体的降解
J Pharm Sci. 2017 Apr;106(4):994-1000. doi: 10.1016/j.xphs.2016.11.021. Epub 2016 Dec 11.
10
Formulation and Administration of Biological Medicinal Products".《生物药物制剂与给药系统》。
Pharm Res. 2020 Aug 2;37(8):159. doi: 10.1007/s11095-020-02859-z.

引用本文的文献

1
Hinge Truncation to Improve Aggregation Kinetics and Thermal Stability of an Antibody Fab Fragment.通过铰链区截短改善抗体Fab片段的聚集动力学和热稳定性
Mol Pharm. 2025 Sep 1;22(9):5389-5399. doi: 10.1021/acs.molpharmaceut.5c00358. Epub 2025 Aug 7.
2
Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow.加速治疗性抗体的表征:icIEF-UV/MS与传统分级分离工作流程的比较评估
J Am Soc Mass Spectrom. 2025 Aug 6;36(8):1641-1649. doi: 10.1021/jasms.5c00058. Epub 2025 Jul 28.
3
Simplified kinetic modeling for predicting the stability of complex biotherapeutics.
用于预测复杂生物治疗药物稳定性的简化动力学模型
Sci Rep. 2025 Jul 1;15(1):22355. doi: 10.1038/s41598-025-07037-y.
4
Physicochemical Comparison of Kolliphor HS 15, ELP, and Conventional Surfactants for Antibody Stabilization in Biopharmaceutical Formulations.聚氧乙烯氢化蓖麻油HS 15、弹性蛋白样多肽(ELP)与传统表面活性剂在生物制药制剂中用于抗体稳定化的物理化学比较
Mol Pharm. 2025 Aug 4;22(8):4890-4908. doi: 10.1021/acs.molpharmaceut.5c00519. Epub 2025 Jun 27.
5
In Vitro Evaluation of the Efficient Passage of PLGA-Formulated Trastuzumab for Nose-to-Brain Delivery.聚乳酸-羟基乙酸共聚物(PLGA)制剂曲妥珠单抗经鼻至脑递送的高效传质体外评价
Pharmaceutics. 2025 May 22;17(6):681. doi: 10.3390/pharmaceutics17060681.
6
Impact of Initial Aggregate Level on Aggregation Potential of Monoclonal Antibodies in Different Buffer Systems.初始聚集体水平对不同缓冲体系中单克隆抗体聚集潜力的影响
Pharm Res. 2025 Jun 6. doi: 10.1007/s11095-025-03874-8.
7
Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability.一流抗癌IgE抗体药物MOv18 IgE的生物物理特性评估表明其具有单体纯度和稳定性。
MAbs. 2025 Dec;17(1):2512211. doi: 10.1080/19420862.2025.2512211. Epub 2025 May 28.
8
A Convenient Strategy for Studying Antibody Aggregation and Inhibition of Aggregation: Characterization and Simulation.一种研究抗体聚集及聚集抑制的便捷策略:表征与模拟
Pharmaceutics. 2025 Apr 19;17(4):534. doi: 10.3390/pharmaceutics17040534.
9
A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2.一种基于聚山梨酯的脂质纳米颗粒疫苗制剂可诱导针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的体内免疫反应。
Pharmaceutics. 2025 Mar 29;17(4):441. doi: 10.3390/pharmaceutics17040441.
10
Reduced IgG1 Antibody Left-Twisted Antiparallel β-Sheet Structure Stability Occurs under Metal-Catalyzed Oxidation Conditions in the Presence of Polysorbates.在聚山梨酯存在的金属催化氧化条件下,IgG1抗体左扭曲反平行β-折叠结构稳定性降低。
Mol Pharm. 2025 May 5;22(5):2623-2638. doi: 10.1021/acs.molpharmaceut.5c00034. Epub 2025 Apr 9.